Our Magazine
Brussels Morning Online Newspaper
Thursday, April 15, 2021
No Result
View All Result
  • Home
    • About Us
  • EU institutions
    • Commission
    • Parliament
    • Council
  • Europe
  • World
  • Economy
  • Culture and Society
  • In Depth
    • Ambassador’s Corner
    • The American Angle
    • Europe With Transparency
    • Sustainable Perspective
    • Place de la Bourse
    • The Macro-Economist
    • Southeast Europe
Brussels Morning Online Newspaper
  • Home
    • About Us
  • EU institutions
    • Commission
    • Parliament
    • Council
  • Europe
  • World
  • Economy
  • Culture and Society
  • In Depth
    • Ambassador’s Corner
    • The American Angle
    • Europe With Transparency
    • Sustainable Perspective
    • Place de la Bourse
    • The Macro-Economist
    • Southeast Europe
Brussels Morning Online Newspaper
No Result
View All Result
Home Europe

UK COVID tests show lower antibodies risking reinfection

Sophia Akram by Sophia Akram
27 October 2020
in Europe
UK COVID tests show lower antibodies risking reinfection
Share on FacebookShare on Twitter

London (Brussels Morning) A study by Imperial College London has shown that antibodies that help the human immune system decline rapidly after catching the coronavirus.

The results are part of the university’s REACT-2 surveillance study looking at the prevalence of antibodies in the community in England.

The tests found positive antibody results fell 26 percent in the third quarter of the year.

As immunity declines, the chance of reinfections grows, lending to the possibility of catching the virus several times.

The findings fly in the face of scientists suggesting herd immunity is a better way to move forward with the pandemic.

Herd immunity is the building up of immunity in a substantial proportion of the population to reduce the risk of infection to the most vulnerable in the community.

To achieve herd immunity, 50-60 percent of the population would need to build resistance to the virus.

Earlier this month a group of leading scientists signed a statement calling for the approach to be adopted, enabling most of the population to resume normal life while better protecting the vulnerable.

“We call this focused protection”, it read.

The Imperial study’s findings also coincided with official figures showing deaths rose by 60 percent in the week of 16 October.

The number of COVID-19 related deaths in the UK has now surpassed 60,000.

The REACT-2 study has tested over 350,000 people. Its June tests found around 60 people in 1,000 had detectable antibodies, while only 44 in 1,000 had those antibodies in September, just three months after the first round of testing.

The decline was starker among those over the age of 65 and among those who were asymptomatic.

Healthcare workers retained a high number of antibodies explained by higher exposure to the virus.

The study did not examine all parts of the immune system, including T-cells, and researchers are quick to point out that the drop in antibodies does not indicate the effectiveness of any vaccine.

There is also hope a second infection would be milder than the first due to the body’s immune memory.

“The need for a vaccine is still very large, the data doesn’t change that”, said researcher Graham Cooke.

Subscribe to Our Newsletter

Tags: antibodiesCovid-19
Sophia Akram

Sophia Akram

Sophia Akram is the Brussels Morning London correspondent. Based in London, Sophia is a journalist with a portfolio rich in human rights, politics and foreign policy coverage, plus extensive experience in Europe, the Middle East and Asia.

Latest post

Now the Digital Markets Act is here, could this be what tames big tech?

Now the Digital Markets Act is here, could this be what tames big tech?

8 hours ago
Pandemic‌ ‌to‌ ‌set‌ ‌French‌ ‌finances‌ ‌back‌ ‌€424bn‌ ‌over‌ ‌three‌ ‌years‌ ‌

Pandemic‌ ‌to‌ ‌set‌ ‌French‌ ‌finances‌ ‌back‌ ‌€424bn‌ ‌over‌ ‌three‌ ‌years‌ ‌

13 hours ago

Most Read

  • A very Georgian provokatsiya

    A very Georgian provokatsiya

    0 shares
    Share 0 Tweet 0
  • The EU’s newest member state Croatia can teach the bloc much about building strategic autonomy

    0 shares
    Share 0 Tweet 0
  • EC to investigate €1bn worth of missing lumber in Croatian forests

    0 shares
    Share 0 Tweet 0
  • Salmond’s strategic masterstroke

    0 shares
    Share 0 Tweet 0
  • Vaccine export bans won’t help the fight against Covid-19, says Pfizer

    0 shares
    Share 0 Tweet 0

Subscribe
Facebook Twitter Youtube LinkedIn

About Us

Brussels Morning is a daily online newspaper based in Belgium. BM publishes unique and independent coverage on international and European affairs. With a Europe-wide perspective, BM covers policies and politics of the EU, significant Member State developments, and looks at the international agenda with a European perspective.

Category

  • Ambassador’s Corner
  • Commission
  • Council
  • Culture and Society
  • Diplomacy
  • Economy
  • EU Institutions
  • Europe
  • Europe With Transparency
  • Features
  • In Depth
  • Member States
  • Middle East Eye
  • Opinion
  • Our pick
  • Parliament
  • Place de la Bourse
  • Southeast Europe
  • Sustainable Perspective
  • The American Angle
  • The Macro-Economist
  • Uncategorised
  • US Elections
  • World

More info

  • About Us
  • Advertising
  • Cookies Policy
  • Contact Us
  • FAQ
  • Jobs

Brussels Morning Newspaper - All Rights Reserved © 2020

No Result
View All Result
  • Home
  • About Us
  • EU Institutions
    • Parliament
    • Commission
    • Council
  • Europe
  • World
  • Member States
  • Economy
  • Culture and Society
  • In Depth
    • Ambassador’s Corner
    • Europe With Transparency
    • Place de la Bourse
    • The Macro-Economist
    • Sustainable Perspective
    • The American Angle
    • Southeast Europe
  • Magazine

Brussels Morning Newspaper - All Rights Reserved © 2020

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Cookie settingsACCEPT
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.

SAVE & ACCEPT